0001140361-12-032877.txt : 20120711
0001140361-12-032877.hdr.sgml : 20120711
20120711123336
ACCESSION NUMBER: 0001140361-12-032877
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20120711
DATE AS OF CHANGE: 20120711
EFFECTIVENESS DATE: 20120711
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-181032
FILM NUMBER: 12957415
BUSINESS ADDRESS:
STREET 1: 201 ROUTE 22
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 201 ROUTE 22
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
D
1
primary_doc.xml
X0706
D
LIVE
0001016504
INTEGRATED BIOPHARMA INC
225 Long Avenue
HILLSIDE
NJ
NEW JERSEY
07205
8002925234
DELAWARE
None
INTEGRATED HEALTH TECHNOLOGIES INC
CHEM INTERNATIONAL INC
Corporation
true
E. Gerald
Kay
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Executive Officer
Director
Christina
Kay
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Executive Officer
Director
Riva
Sheppard
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Executive Officer
Director
Dina
L.
Masi
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Executive Officer
Robert
Canarick
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Director
William
Milmoe
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Director
Carl
De Santis
225 Long Avenue
Hillside
NJ
NEW JERSEY
07205
Director
Other Health Care
$25,000,001 - $100,000,000
- 06
false
2012-06-27
false
true
true
true
Secured convertible promissory note and the underlying shares of common stock issuable upon conversion thereof.
false
0
5350000
5350000
0
Secured convertible note, in the original principal amount of $5,350,000, convertible into common stock of the Issuer at a conversion price of $0.65, subject to customary adjustments.
false
1
0
0
0
false
INTEGRATED BIOPHARMA INC
/s/ Dina L. Masi
Diina L. Masi
Chief Financial Officer
2012-07-11